Dr. McMurry-Heath is the Founder and CEO of BioTechquity Clinical, a novel clinical research organization designed to help drug and device innovators enroll and conduct diverse clinical trials. BioTechquity ends our conflation of race and poverty to find previously untapped diverse middle class patient partners. Partners better equipped to complete trials and lower the average 40% attrition rate seen in most modern trials. Before founding BioTechquity, she was the CEO of the Biotechnology Innovation Organization (BIO) where she launched the industry-wide BIOEquality Agenda. She is a former regulatory and clinical leader at both the US Food & Drug Administration (FDA) and Johnson&Johnson where she led a global team responsible for trials and regulatory approvals in 150 countries. She has experience on Capitol Hill and was the Founding Director of the Aspen Institute health program. Dr. McMurry-Heath has committed her career to the belief that medical innovation can improve lives and unlock opportunity for all people if inclusively conducted and equitably distributed. And that it will take market savvy innovations and breakthrough business models to achieve meaningful BioTech Equity.
